Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04UTH
|
|||
Former ID |
DIB005808
|
|||
Drug Name |
Long-acting erythropoietin conjugate
|
|||
Synonyms |
HM-10760; HM-10760A; LAPS-EPO; Long-acting erythropoietin conjugate (LAPS, anemia); Long-acting erythropoietin conjugate (LAPS, anemia), Hanmi
Click to Show/Hide
|
|||
Indication | Anemia [ICD-11: 3A00-3A9Z; ICD-9: 280-285] | Phase 1 | [1] | |
Company |
Hanmi pharmaceutical
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Erythropoietin (EPO) | Target Info | Modulator | [2] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
HIF-1 signaling pathway | ||||
PI3K-Akt signaling pathway | ||||
Jak-STAT signaling pathway | ||||
Hematopoietic cell lineage | ||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | |||
Signaling events mediated by Stem cell factor receptor (c-Kit) | ||||
EPO signaling pathway | ||||
HIF-1-alpha transcription factor network | ||||
Reactome | Regulation of gene expression by Hypoxia-inducible Factor | |||
WikiPathways | EPO Receptor Signaling | |||
Hematopoietic Stem Cell Differentiation | ||||
Differentiation Pathway | ||||
Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01030315) A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects. U.S. National Institutes of Health. | |||
REF 2 | Company report (Pharmexcil) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.